MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 2, 2004; DOI: 10.1124/mol.104.007278


0026-895X/05/6703-681-694$20.00
Mol Pharmacol 67:681-694, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.007278v1
67/3/681    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stauber, A. J.
Right arrow Articles by Corton, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stauber, A. J.
Right arrow Articles by Corton, J. C.
ORIGINAL ARTICLE

Constitutive Expression of Peroxisome Proliferator-Activated Receptor {alpha}-Regulated Genes in Dwarf Mice

Anja J. Stauber1, Holly Brown-Borg, Jie Liu, Michael P. Waalkes, Ashley Laughter, Rebecca A. Staben, Jaqueline C. Coley, Cynthia Swanson, Kenneth A. Voss, John J. Kopchick, and J. Christopher Corton

CIIT Centers for Health Research, Research Triangle Park, North Carolina (A.J.S., A.L., R.A.S., J.C.C., C.S.); Department of Pharmacology, Physiology, and Therapeutics, University of North Dakota School of Medicine, Grand Forks, North Dakota (H.B.B.); National Cancer Institute and National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina (J.L., M.P.W.), Toxicology and Mycotoxin Research Unit, Agricultural Research Service, United States Department of Agriculture, Athens, Georgia (K.A.V.), Department of Biomedical Sciences, College of Osteopathic Medicine and Edison Biotechnology Institute, Ohio University, Athens, Ohio (J.J.K.), and ToxicoGenomics, Chapel Hill, North Carolina (J.C.C.)

Abstract

Defects in growth hormone secretion or signaling in mice are associated with decreased body weights (dwarfism), increased longevity, increased resistance to stress, and decreases in factors that contribute to cardiovascular disease and cancer. Peroxisome proliferators (PP) alter a subset of these changes in wild-type mice through activation of the nuclear receptor family member PP-activated receptor {alpha} (PPAR{alpha}). We tested the hypothesis that an overlap in the transcriptional programs between untreated dwarf mice and PP-treated wild-type mice underlies these similarities. Using transcript profiling, we observed a statistically significant overlap in the expression of genes differentially regulated in control Snell dwarf mice (Pit-1dw) compared with phenotypically normal heterozygote (+/dw) control mice and those altered by the PP 4-chloro-6-(2,3-xylidino)-2-pyrimidinyl)thioacetic acid (WY-14,643) in +/dw mice. The genes included those involved in {beta}- and {omega}-oxidation of fatty acids (Acox1, Cyp4a10, Cyp4a14) and those involved in stress responses (the chaperonin, T-complex protein1{epsilon}) and cardiovascular disease (fibrinogen). The levels of some of these gene products were also altered in other dwarf mouse models, including Ames, Little, and growth hormone receptor-null mice. The constitutive increases in PPAR{alpha}-regulated genes may be partly caused by increased expression of PPAR{alpha} mRNA and protein as observed in the livers of control Snell dwarf mice. These results indicate that some of the beneficial effects associated with the dwarf phenotype may be caused by constitutive activation of PPAR{alpha} and regulated genes.


Received September 15, 2004; accepted November 29, 2004

Address correspondence to: J. Christopher Corton, ToxicoGenomics, 209 Silver Creek Tr., Chapel Hill, NC 27514. E-mail: ccorton{at}msn.com




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. Biserni, F. Giannessi, A. F. Sciarroni, F. M. Milazzo, A. Maggi, and P. Ciana
In Vivo Imaging Reveals Selective Peroxisome Proliferator Activated Receptor Modulator Activity of the Synthetic Ligand 3-(1-(4-Chlorobenzyl)-3-t-butylthio-5-isopropylindol-2-yl)-2,2-dimethylpropanoic acid (MK-886)
Mol. Pharmacol., May 1, 2008; 73(5): 1434 - 1443.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
Q. Yang, T. Nagano, Y. Shah, C. Cheung, S. Ito, and F. J. Gonzalez
The PPAR{alpha}-Humanized Mouse: A Model to Investigate Species Differences in Liver Toxicity Mediated by PPAR{alpha}
Toxicol. Sci., January 1, 2008; 101(1): 132 - 139.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. L. Brooks, C. M. Trent, C. F. Raetzsch, K. Flurkey, G. Boysen, M. T. Perfetti, Y.-C. Jeong, S. Klebanov, K. B. Patel, V. R. Khodush, et al.
Low Utilization of Circulating Glucose after Food Withdrawal in Snell Dwarf Mice
J. Biol. Chem., November 30, 2007; 282(48): 35069 - 35077.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. Ciana, A. Biserni, L. Tatangelo, C. Tiveron, A. F. Sciarroni, L. Ottobrini, and A. Maggi
A Novel Peroxisome Proliferator-Activated Receptor Responsive Element-Luciferase Reporter Mouse Reveals Gender Specificity of Peroxisome Proliferator-Activated Receptor Activity in Liver
Mol. Endocrinol., February 1, 2007; 21(2): 388 - 400.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. Yoon, G. Peng, Y. Brandenburg, O. Zollo, W. Xu, E. Rego, and D. Ruggero
Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita.
Science, May 12, 2006; 312(5775): 902 - 906.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. C. Corton and H. M. Brown-Borg
Peroxisome Proliferator-Activated Receptor {gamma} Coactivator 1 in Caloric Restriction and Other Models of Longevity
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2005; 60(12): 1494 - 1509.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics